Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07638982 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Axatilimab + CAR-T for High-Risk Lymphoma

StatusNot Yet Recruiting
PhasePhase 1
Started
View on ClinicalTrials.gov ↗

Record History

  1. Minor Study First Submitted
Axatilimab + CAR-T in High-Risk Lymphoma
Trial Details
NCT Number NCT07638982
Lead Sponsor Northside Hospital, Inc.
Conditions
(from sponsor)
Diffuse Large B Cell Lymphoma (DLBCL), Transformed Indolent B-Cell Non-Hodgkin Lymphoma to Diffuse Large B-Cell Lymphoma, High-grade B-cell Lymphoma (HGBCL), High-Grade B-Cell Lymphoma, Nos, PMBCL, Follicular Grade 3 Lymphoma
Related terms Lymphoma, Follicular, Lymphoma, Large B-Cell, Diffuse, Pyloric Stenosis, Hypertrophic
Enrollment 29 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov